eFFECTOR Therapeutics, Inc. Warrant

EFTRW

...

EFTRW: eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

Show EFTRW Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of EFTRW by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by EFTRW's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on EFTRW's company Twitter account

WallStreetBets

Number of mentions of EFTRW in WallStreetBets Daily Discussion

EFTRW News

Recent insights relating to EFTRW

CNBC Recommendations

Recent picks made for EFTRW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EFTRW

Corporate Flights

Flights by private jets registered to EFTRW